APLS
APLS
NASDAQ · Biotechnology

Apellis Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$41.03
+0.02 (+0.05%)
As of May 9, 1:25 AM ET ·
Earnings History
Date Quarter EPS Est EPS Actual Surprise Surprise % Result
May 5, 2026 Q2 FY2026 $-0.36 — — — —
Feb 24, 2026 Q1 FY2026 $-0.39 — — — —
Related Earnings News
Biogen Acquires Apellis in $5.6B Deal, Adding Eye and Kidney Drugs
Markets ·
Biogen to Acquire Apellis in $5.6B Deal, Adding Rare Disease Portfolio
Markets ·